<DOC>
	<DOC>NCT01551563</DOC>
	<brief_summary>The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.</brief_summary>
	<brief_title>Stavanger University Hospital Inflammatory Bowel Disease Trial</brief_title>
	<detailed_description>none considered needed</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>newly diagnosed IBD previous IBD with specific treatment within 10 year inability to consent inability to adhere to treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>